The U.S. Food and Drug Administration (FDA) has selected Booz Allen Hamilton to support development, modernization, and enhancement of the FDA Adverse Event Reporting System (FAERS). As part of this work, the Agency will deploy ArisGlobal’s LifeSphere MultiVigilance (LSMV) platform to replace part of its current pharmacovigilance system that will intake, triage and process safety reports and make them available for review and analysis.

ArisGlobal announced that the health authority (HA) of the largest country in East Asia has selected and implemented LifeSphere Safety MultiVigilance (also known as ARISc) solution for clinical safety and pharmacovigilance (PV) through its local partner.

ArisGlobal, a leading life sciences technology provider, announced the launch of LifeSphere MultiVigilance – the next-generation platform for individual case safety report (ICSR) intake powered by LifeSphere Nava – ArisGlobal’s cognitive computing engine.

ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences and APCER Life Sciences the industry preferred end-to-end pharmacovigilance services provider, today globally unveiled the first seamlessly integrated cloud technology and pharmacovigilance services platform. The joint managed services plugs in one of the most critical PV compliance gaps of the pharma industry with proven gold blueprint from 40+ organizations and regulatory bodies in 160 countries.

ArisGlobal, LLC, a leading provider of integrated cloud-based software solutions for life sciences, will present a session titled “Precision Pharmacovigilance: Is this the Way Forward?” at the upcoming World Drug Safety Congress Europe conference to be held in Amsterdam from September 10-11, 2018.

Dohmen Life Science Services selects Lifesphere Safety Multivigilance, adding cognitive computing to best-in-class pharmacovigilance, medical communication & commercial services

ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences and APCER Life Sciences the industry preferred end-to-end pharmacovigilance services provider, today globally unveiled the first seamlessly integrated cloud technology and pharmacovigilance services platform. The joint managed services plugs in one of the most critical PV compliance gaps of the pharma industry with proven gold blueprint from 40+ organizations and regulatory bodies in 160 countries.

ArisGlobal selected as preferred partner by Celegence, a global regulatory affairs services provider, as its preferred partner for RIMS and IDMP Business Process-as-a-Service Offering enabling Life Sciences companies to leverage an innovative, efficient and cost-effective model for regulatory compliance. Read more

ArisGlobal’s session on July 2 at World Congress on Regulatory Affairs for Medical Devices, “Can Medical Devices Learn from Pharma: Shared Challenges, Similar Opportunities,” will focus on how regulatory information management data can be viewed as an asset, creating opportunities for automation and productivity gains.

ArisGlobal announced that the health authority (HA) of the largest country in East Asia has selected and implemented LifeSphere Safety MultiVigilance (also known as ARISc) solution for clinical safety and pharmacovigilance (PV) through its local partner.